Banner Image

Test Directory

Myelin Basic Protein

Test Summary

The concentration of MBP is often increased in patients with demyelinating diseases such as multiple sclerosis and may be increased in patients with head injury, CNS trauma, tumor, stroke, and viral encephalitis.

Aliases

  • N/A

Specimen Collection

Special Instructions

N/A

Preferred Specimen

1.2 mL CSF collected in a sterile CSF collection tube #4

Minimum Volume

0.5 mL

Instructions

Do not centrifuge CSF. Refrigerate CSF and send refrigerated (cold packs) or freeze CSF specimens -20 degrees C or lower and send frozen samples on dry ice to the laboratory.

Blood contamination and hemolysis may interfere with results. CSF must be clear. Submitting 4th lumbar puncture collection tube minimizes blood contamination.

Patient Preparation

N/A

Storage

N/A

Transport Temperature

Frozen

Specimen Stability

  • Room temperature 7 days
  • Refrigerated 14 days
  • Frozen 21 days

Limitations

The presence of myelin basic protein in the spinal fluid is supportive evidence for the diagnosis of multiple sclerosis and other demyelinating diseases, although it is a non-specific finding and present in other causes of damage to CNS myelin.

Other Acceptable Specimens

N/A

Unacceptable Specimens

xanthochromia/RBCs/hemolysis in CSF

Order Code

MBP

EPIC (Premier) Code

LAB307

Includes

N/A

CPT Code

  • 83873

Billing Code

  • 670158

CPT Statement

Methodology

Radioimmunoassay (RIA)

FDA Status

This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Physician Attestation of Informed Consent

N/A

Testing Laboratory

Quest Diagnostics Nichols Institute
14225 Newbrook Drive
Chantilly VA, 20153

Department

Reference Testing

Reference Range

≤4.0 mcg/LNegative
4.1-6.0 mcg/LWeakly positive
>6.0 mcg/LPositive

Setup Schedule / Expected Turnaround Time

Monday, Thursday; Reports available: 3 - 7 days

Specimen Collection

Special Instructions

N/A

Preferred Specimen

1.2 mL CSF collected in a sterile CSF collection tube #4

Minimum Volume

0.5 mL

Instructions

Do not centrifuge CSF. Refrigerate CSF and send refrigerated (cold packs) or freeze CSF specimens -20 degrees C or lower and send frozen samples on dry ice to the laboratory.

Blood contamination and hemolysis may interfere with results. CSF must be clear. Submitting 4th lumbar puncture collection tube minimizes blood contamination.

Patient Preparation

N/A

Storage

N/A

Transport Temperature

Frozen

Specimen Stability

  • Room temperature 7 days
  • Refrigerated 14 days
  • Frozen 21 days

Limitations

The presence of myelin basic protein in the spinal fluid is supportive evidence for the diagnosis of multiple sclerosis and other demyelinating diseases, although it is a non-specific finding and present in other causes of damage to CNS myelin.

Other Acceptable Specimens

N/A

Unacceptable Specimens

xanthochromia/RBCs/hemolysis in CSF

Billing

CPT Code

  • 83873

Billing Code

  • 670158

CPT Statement

Result Information

Methodology

Radioimmunoassay (RIA)

Testing Laboratory

N/A

Reference Range

≤4.0 mcg/LNegative
4.1-6.0 mcg/LWeakly positive
>6.0 mcg/LPositive

Setup Schedule / Expected Turnaround Time

Monday, Thursday; Reports available: 3 - 7 days